{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:22:15Z","timestamp":1792686135609,"version":"4.5.0"},"reference-count":56,"publisher":"Georg Thieme Verlag KG","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patient care pathways provide an integrated care approach to atrial fibrillation (AF) management. International guidelines propose various patient care pathways, each emphasizing different strategies for assessing stroke and bleeding risk. Due to different ethnicities and susceptibility to stroke or bleeding risk, caution should be taken during application of Western cohorts-derived patient care pathways to Asian cohorts. Evidence-based rather than eminence-based strategies should be adopted for AF patient care. In this clinical focus, we summarize and compare patient care pathways, using evidence on the implementation in real-world registries, and strategies for assessing stroke and bleeding risk across Asian and non-Asian guidelines.<\/jats:p>","DOI":"10.1055\/a-2595-5575","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:51:58Z","timestamp":1747770718000},"page":"1173-1180","source":"Crossref","is-referenced-by-count":39,"title":["Patient Care Pathways and Risk Assessments in Patients with Atrial Fibrillation: A Comparison of Asian versus Non-Asian Cohorts"],"prefix":"10.1055","volume":"125","author":[{"given":"Hao-Chih","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsin","family":"Chan","sequence":"additional","affiliation":[{"name":"The Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"},{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Microscopy Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Kuo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze-Fan","family":"Chao","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"100786","DOI":"10.1016\/j.lanepe.2023.100786","article-title":"Atrial fibrillation: epidemiology, screening and digital health","volume":"37","author":"D Linz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41569-024-01091-1","article-title":"The burden of atrial fibrillation in the Asia-Pacific region","volume":"21","author":"C X Wong","year":"2024","journal-title":"Nat Rev Cardiol"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chest.2017.10.001","article-title":"Lifetime risks, projected numbers, and adverse outcomes in Asian patients with atrial fibrillation: a report from the Taiwan nationwide AF cohort study","volume":"153","author":"T F Chao","year":"2018","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ahj.2018.04.017","article-title":"10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population","volume":"202","author":"D Kim","year":"2018","journal-title":"Am Heart J"},{"issue":"04","key":"ref5","first-page":"810","article-title":"The global burden of atrial fibrillation and stroke: a systematic review of the clinical epidemiology of atrial fibrillation in Asia","volume":"152","author":"Y Bai","year":"2017","journal-title":"Chest"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"G YH Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"T F Chao","year":"2022","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"J A Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"ref9","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"I C Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/a-2325-5923","article-title":"2024 Chinese expert consensus guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): executive summary","volume":"124","author":"Y Wang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/a-2434-9244","article-title":"The 2024 European Society of Cardiology guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician's perspective","volume":"124","author":"T Potpara","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"102039","DOI":"10.1016\/j.eclinm.2023.102039","article-title":"Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry","volume":"63","author":"G F Romiti","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2017.10.085","article-title":"Relationship of aging and incident comorbidities to stroke risk in patients with atrial fibrillation","volume":"71","author":"T F Chao","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1055\/s-0039-1683933","article-title":"Incident co-morbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): implications for reassessment of stroke risk in initially \u201clow-risk\u201d patients","volume":"119","author":"T F Chao","year":"2019","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.amjmed.2018.06.012","article-title":"Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (Atrial fibrillation Better Care) pathway","volume":"131","author":"M Proietti","year":"2018","journal-title":"Am J Med"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1055\/s-0039-1693516","article-title":"Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC (Atrial fibrillation Better Care) pathway for integrated care management: a nationwide cohort study","volume":"119","author":"M Yoon","year":"2019","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/europace\/euab092","article-title":"The Atrial fibrillation Better Care pathway for managing atrial fibrillation: a review","volume":"23","author":"D Stevens","year":"2021","journal-title":"Europace"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u201cAtrial fibrillation Better Care\u201d pathway in patients with atrial fibrillation: impact on clinical outcomes\u2014a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"G F Romiti","year":"2022","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jacasi.2023.04.008","article-title":"Integrated care for atrial fibrillation using the ABC pathway in the prospective APHRS-AF registry","volume":"3","author":"T Bucci","year":"2023","journal-title":"JACC Asia"},{"issue":"13","key":"ref20","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Y Guo","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jacasi.2024.07.006","article-title":"A novel model of integrated care of older patients with atrial fibrillation in rural China","volume":"4","author":"M Li","year":"2024","journal-title":"JACC Asia"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41591-025-03511-2","article-title":"Telemedicine-based integrated management of atrial fibrillation in village clinics: a cluster randomized trial","volume":"31","author":"M Chu","year":"2025","journal-title":"Nat Med"},{"issue":"31","key":"ref23","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1093\/eurheartj\/ehac265","article-title":"A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium","volume":"43","author":"S P Johnsen","year":"2022","journal-title":"Eur Heart J"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"e29408","DOI":"10.2196\/29408","article-title":"Cost-effectiveness of mobile health-based integrated care for atrial fibrillation: model development and data analysis","volume":"24","author":"X Luo","year":"2022","journal-title":"J Med Internet Res"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ehjqcco\/qcad055","article-title":"Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040","volume":"10","author":"E M Camacho","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"G Y Lip","year":"2010","journal-title":"Chest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijcard.2015.05.115","article-title":"The CHADS2 and CHA2DS2-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: a systemic review and meta-analysis","volume":"195","author":"Q Xiong","year":"2015","journal-title":"Int J Cardiol"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.hrthm.2015.08.017","article-title":"Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: which scoring system should be used for Asians?","volume":"13","author":"T F Chao","year":"2016","journal-title":"Heart Rhythm"},{"issue":"08","key":"ref29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1253\/circj.CJ-16-1267","article-title":"Risk of ischemic stroke in patients with non-valvular atrial fibrillation not receiving oral anticoagulants\u2014Korean nationwide population-based study","volume":"81","author":"S H Kang","year":"2017","journal-title":"Circ J"},{"issue":"06","key":"ref30","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/STROKEAHA.117.016926","article-title":"CHA2DS2-VASc score (congestive heart failure, hypertension, age \u226575 [doubled], diabetes mellitus, prior stroke or transient ischemic attack [doubled], vascular disease, age 65-74, female) for stroke in Asian patients with atrial fibrillation: a Korean nationwide sample cohort study","volume":"48","author":"T H Kim","year":"2017","journal-title":"Stroke"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-0043-1776394","article-title":"Sex as a risk factor for atrial fibrillation-related stroke","volume":"124","author":"B Corica","year":"2024","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref32","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: should we use a CHA2DS2-VA score rather than CHA2DS2-VASc?","volume":"137","author":"P B Nielsen","year":"2018","journal-title":"Circulation"},{"issue":"36","key":"ref33","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1093\/eurheartj\/ehae540","article-title":"CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications","volume":"45","author":"G YH Lip","year":"2024","journal-title":"Eur Heart J"},{"issue":"19","key":"ref34","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehy837","article-title":"Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities","volume":"40","author":"T F Chao","year":"2019","journal-title":"Eur Heart J"},{"issue":"05","key":"ref35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"R Pisters","year":"2010","journal-title":"Chest"},{"issue":"03","key":"ref36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"B F Gage","year":"2006","journal-title":"Am Heart J"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"M C Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1055\/s-0042-1750385","article-title":"Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus paper","volume":"122","author":"D A Gorog","year":"2022","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/a-2278-8769","article-title":"Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study","volume":"124","author":"D S Kang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/a-2269-1123","article-title":"Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects","volume":"124","author":"D S Kang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0040-1718729","article-title":"The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease","volume":"121","author":"H K Kim","year":"2021","journal-title":"Thromb Haemost"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"757087","DOI":"10.3389\/fcvm.2021.757087","article-title":"Diagnostic accuracy of the HAS-BLED bleeding score in VKA- or DOAC-treated patients with atrial fibrillation: a systematic review and meta-analysis","volume":"8","author":"X Gao","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"23","key":"ref43","doi-asserted-by":"crossref","first-page":"e026388","DOI":"10.1161\/JAHA.121.026388","article-title":"Performance of the HAS-BLED, ORBIT, and ATRIA bleeding risk scores on a cohort of 399\u2009344 hospitalized patients with atrial fibrillation and cancer: data from the French national hospital discharge database","volume":"11","author":"D Pastori","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"02","key":"ref44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.amjmed.2017.09.009","article-title":"Comparing bleeding risk assessment focused on modifiable risk factors only versus validated bleeding risk scores in atrial fibrillation","volume":"131","author":"Y Guo","year":"2018","journal-title":"Am J Med"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1160\/TH17-10-0710","article-title":"Assessing bleeding risk in atrial fibrillation patients: comparing a bleeding risk score based only on modifiable bleeding risk factors against the HAS-BLED score. The AMADEUS trial","volume":"117","author":"M A Esteve-Pastor","year":"2017","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref46","first-page":"835","article-title":"Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients","volume":"77","author":"M J Serna","year":"2024","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"03","key":"ref47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10840-014-9930-y","article-title":"Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"40","author":"D Caldeira","year":"2014","journal-title":"J Interv Card Electrophysiol"},{"issue":"07","key":"ref48","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/ehjqcco\/qcab069","article-title":"Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry","volume":"8","author":"M Proietti","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"09","key":"ref49","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","article-title":"Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study","volume":"60","author":"S Apostolakis","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"ref50","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.amjmed.2020.03.019","article-title":"Regular bleeding risk assessment associated with reduction in bleeding outcomes: the mAFA-II randomized trial","volume":"133","author":"Y Guo","year":"2020","journal-title":"Am J Med"},{"issue":"05","key":"ref51","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/ehjqcco\/qcab050","article-title":"Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study","volume":"8","author":"T F Chao","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/03007995.2016.1275936","article-title":"Stroke risk reduction outweighed bleeding risk increase from vitamin K antagonist treatment among nonvalvular atrial fibrillation patients with high stroke risk and low bleeding risk","volume":"33","author":"W W Nelson","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ahj.2023.03.012","article-title":"Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores","volume":"261","author":"Z Hijazi","year":"2023","journal-title":"Am Heart J"},{"issue":"12","key":"ref54","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/CIRCULATIONAHA.123.064556","article-title":"Development and validation of the DOAC score: a novel bleeding risk prediction tool for patients with atrial fibrillation on direct-acting oral anticoagulants","volume":"148","author":"R Aggarwal","year":"2023","journal-title":"Circulation"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejim.2024.06.022","article-title":"Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: a report from a prospective European observational registry","volume":"128","author":"D A Mei","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"06","key":"ref56","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/bcp.16396","article-title":"Assessing the applicability of the DOAC, HAS-BLED and ORBIT risk scores in Chinese patients on non-vitamin K antagonist oral anticoagulants","volume":"91","author":"M Fan","year":"2025","journal-title":"Br J Clin Pharmacol"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2595-5575.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:10:31Z","timestamp":1764288631000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2595-5575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,11,27]]},"published-print":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2595-5575","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]}}}